SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease
Clinical trial NCT03867487 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT03867487
- Sponsor
- Justin Ryder
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2027-05-01
- Primary completion
- 2028-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.